HCPLive

Emergency Care Providers Have Poor Hand Hygiene

THURSDAY, Nov. 14 (HealthDay News) -- Only 13 percent of emergency medical personnel say they clean their hands before touching patients, according to the results of a survey presented at the annual meeting of the American College of Emergency Physicians, held from Oct. 14 to 17 in Seattle.

Josh Bucher, MD, from the Robert Wood Johnson Hospital in Piscataway, NJ, and colleagues surveyed nearly 1,500 emergency care providers regarding their demographics and hand washing practices.

The researchers found that only 52 percent of the respondents -- which included first responders, emergency medical providers, paramedics, and doctors -- said that they wear gloves for every patient contact. Only 33 percent of emergency medical providers said they cleaned their hands after performing invasive procedures, and only 13 percent said they clean their hands before touching patients. In addition, only 13 percent of respondents said they cleaned their stethoscope between patients.

"In one of the largest studies of emergency medical services [EMS] provider hand hygiene to date, this study found several areas of EMS provider hand hygiene that are less than ideal," the authors write. "These are all very troubling findings, and they all identify areas where further education can provide direct results and increase hygiene compliance in these critical situations."

Abstract (subscription or payment may be required)
More Information

Copyright © 2013 HealthDay. All rights reserved.

Most Popular

Recommended Reading

Medications in general can take a long time to develop. Depending on the condition they treat that process can be even longer as more questions have to be answered before they can be introduced to the field. This is particularly true of multiple sclerosis treatments.
As a treatment for multiple sclerosis teriflunomide has shown benefits over a long development period and has proven effective in the treatment of patients with the relapsing-remitting form of the condition.
For as many drugs and therapies as there are for multiple sclerosis some are more aggressive than others. Alemtuzumab's approach is more on the aggressive end of the spectrum.
During a time when antibiotic resistance concerns are at an all-time high, a Texas-based team called for backup in the fight against pneumonia.
$vAR$